| Literature DB >> 33593700 |
Lucas Campos Garcia1, Everton Carlos Siviero do Vale2, Maria de Lourdes Ferrari3, Lauro Damasceno de Carvalho Faria3.
Abstract
As the treatment of infectious and parasitic diseases improved, the prevalence of these conditions declined. However, with the expansion of the use of immunobiologicals, opportunistic infections have emerged, especially under atypical presentations. The present study reports the case of a patient treated with infliximab for Crohn's disease, who presented diarrhea, weight loss, abdominal pain, fever, and subcutaneous erythematous nodules that evolved with spontaneous fluctuation and ulceration. With the finding of alcohol-resistant bacilli and Mycobacterium tuberculosis DNA in a cutaneous fragment, through polymerase chain reaction, the diagnosis of gummatous tuberculosis was confirmed, probably secondary to hematogenous dissemination from an intestinal focus.Entities:
Keywords: Crohn's disease; Molecular target therapy; Skin tuberculosis; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
Mesh:
Substances:
Year: 2021 PMID: 33593700 PMCID: PMC8007547 DOI: 10.1016/j.abd.2020.07.008
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Figure 1Ulcerated nodules on the posterior region of the right thigh.
Figure 2Colonoscopy showing an extensive ulcerated inflammatory process in the colon and ileum.
Figure 3Non-caseating granulomas in the ileal mucosa (Hematoxylin & eosin, ×10).
Figure 4Presence of acid-alcohol-fast bacilli (AAFB; arrow) at histopathological examination of the skin (Ziehl-Neelsen, ×100).